KPRX (Kiora Pharmaceuticals) Days Payable: 0.00 (As of Mar. 2026)

What is Kiora Pharmaceuticals Days Payable?

Kiora Pharmaceuticals KPRX -0.78% 34 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates KPRX with a GF Score™ of 34/100. The stock has 3 warning signs investors should review. Among 707 Biotechnology companies, Kiora Pharmaceuticals ranks worse than 141442.57% on this metric.

Kiora Pharmaceuticals's average Accounts Payable for the three months ended in Mar. 2026 was $0.83 Mil. Kiora Pharmaceuticals's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.00 Mil.

The historical rank and industry rank for Kiora Pharmaceuticals's Days Payable or its related term are showing as below:

KPRX's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.76
* Ranked among companies with meaningful Days Payable only.

Kiora Pharmaceuticals's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

Kiora Pharmaceuticals Days Payable Related Terms

Kiora Pharmaceuticals Days Payable Historical Data

* Premium members only.

The historical data trend for Kiora Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kiora Pharmaceuticals Days Payable Chart

Kiora Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Days Payable

Get a 7-Day Free Trial

0.00

Kiora Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

KPRX vs BRTX, INTS, ERNA: Days Payable Comparison

For the Biotechnology subindustry, Kiora Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kiora Pharmaceuticals Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kiora Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Kiora Pharmaceuticals's Days Payable falls into.

Save Embed

34GF Score

Kiora Pharmaceuticals Inc KPRX

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Kiora Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Kiora Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

	Days Payable (A: Dec. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2024 )	+	Accounts Payable (A: Dec. 2025 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2025 )	*	Days in Period
=	( (0.416	+	1.06)	/	2 )	/	0	*	365
=	0.738					/	0	*	365
=	N/A

Kiora Pharmaceuticals's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

	Days Payable (Q: Mar. 2026 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2025 )	+	Accounts Payable (Q: Mar. 2026 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
=	( (1.06	+	0.595)	/	2 )	/	0	*	365 / 4
=	0.8275					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

Kiora Pharmaceuticals (KPRX) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kiora Pharmaceuticals and its competitors. According to the industry distribution chart, Kiora Pharmaceuticals ranks #999999 out of 707 companies in the Biotechnology industry.

Is Kiora Pharmaceuticals' Days Payable too high?

Kiora Pharmaceuticals' current Days Payable is 0.00. Based on the distribution chart, Kiora Pharmaceuticals ranks #999999 out of 707 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Kiora Pharmaceuticals has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.

How does Kiora Pharmaceuticals' Days Payable compare to BRTX and INTS?

According to the Biotechnology industry distribution chart, Kiora Pharmaceuticals ranks #999999 out of 707 companies for Days Payable. This places Kiora Pharmaceuticals in the lower half of its industry. The industry median Days Payable is 113.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.76, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kiora Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kiora Pharmaceuticals's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Kiora Pharmaceuticals stock overvalued right now?

Kiora Pharmaceuticals (KPRX) has a current Days Payable of 0.00. The current Days Payable is 0.00. Kiora Pharmaceuticals' overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For Kiora Pharmaceuticals (KPRX), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kiora Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies BRTX INTS ERNA PHGE PHIO CALC TOVX JUNS APRE KAPA VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 169 Saxony Road, Suite 212, Encinitas, CA, USA, 92024

Website https://www.kiorapharma.com

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

34GF Score

Get the complete analysis for KPRX

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.54

Price

View KPRX Analysis

See Days Payable data for all stocks →